Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Alpine Immune Sciences stock

Learn how to easily invest in Alpine Immune Sciences stock.

Alpine Immune Sciences Inc is a biotechnology business based in the US. Alpine Immune Sciences shares (ALPN) are listed on the NASDAQ and all prices are listed in US Dollars. Alpine Immune Sciences employs 85 staff and has a trailing 12-month revenue of around $32 million.

How to buy shares in Alpine Immune Sciences

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – ALPN – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Alpine Immune Sciences stock price (NASDAQ: ALPN)

Use our graph to track the performance of ALPN stocks over time.

Alpine Immune Sciences shares at a glance

Information last updated 2022-09-24.
Latest market close$6.89
52-week range$6.00 - $14.40
50-day moving average $8.22
200-day moving average $8.94
Wall St. target price$21.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-1.75

Buy Alpine Immune Sciences shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 7 of 7
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$0
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Public
Stocks, ETFs, Cryptocurrency
$0
$0
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$100
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Tradier
Stocks, Options, ETFs
$0
$0
N/A
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Alpine Immune Sciences stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Alpine Immune Sciences price performance over time

Historical closes compared with the close of $6.89 from 2022-09-23

1 week (2022-09-19) -8.86%
1 month (2022-08-26) -13.88%
3 months (2022-06-24) -20.80%
6 months (2022-03-22) N/A
1 year (2021-09-24) -33.49%
2 years (2020-09-25) -15.77%
3 years (2019-09-26) 75.77%
5 years (2017-09-26) 11.11

Alpine Immune Sciences financials

Revenue TTM $32 million
Gross profit TTM $-35,299,000
Return on assets TTM -17.5%
Return on equity TTM -75.73%
Profit margin -169.82%
Book value $3.28
Market capitalisation $303.2 million

TTM: trailing 12 months

Alpine Immune Sciences share dividends

We're not expecting Alpine Immune Sciences to pay a dividend over the next 12 months.

Have Alpine Immune Sciences's shares ever split?

Alpine Immune Sciences's shares were split on a 1:4 basis on 24 July 2017. So if you had owned 4 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Alpine Immune Sciences shares – just the quantity. However, indirectly, the new 300% higher share price could have impacted the market appetite for Alpine Immune Sciences shares which in turn could have impacted Alpine Immune Sciences's share price.

Alpine Immune Sciences share price volatility

Over the last 12 months, Alpine Immune Sciences's shares have ranged in value from as little as $6 up to $14.4. A popular way to gauge a stock's volatility is its "beta".

ALPN.US volatility(beta: 1.59)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Alpine Immune Sciences's is 1.5881. This would suggest that Alpine Immune Sciences's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).

Alpine Immune Sciences overview

Alpine Immune Sciences, Inc. , a clinical-stage biopharmaceutical company, focuses on the discovery and development of protein-based immunotherapies for the treatment of cancer, autoimmune/inflammatory disorders, and other diseases. Its product pipeline includes ALPN-101, an inducible T cell costimulator (ICOS)/cluster of differentiation 28 (CD28) antagonist program for the treatment of autoimmune and inflammatory diseases; ALPN-202, a conditional CD28 costimulator and dual checkpoint inhibitor for the treatment of cancer; and ALPN-303, a dual B cell cytokine antagonist for the treatment of B cell-mediated inflammatory and autoimmune diseases. The company has a collaboration agreement with AbbVie Ireland Unlimited Company for the development of ALPN-101; and Adaptimmune Therapeutics plc to develop next-generation SPEAR T cell products. Alpine Immune Sciences, Inc. was incorporated in 2007 and is headquartered in Seattle, Washington. .

Frequently asked questions

What percentage of Alpine Immune Sciences is owned by insiders or institutions?
Currently 6.942% of Alpine Immune Sciences shares are held by insiders and 54.959% by institutions.
How many people work for Alpine Immune Sciences?
Latest data suggests 85 work at Alpine Immune Sciences.
When does the fiscal year end for Alpine Immune Sciences?
Alpine Immune Sciences's fiscal year ends in December.
Where is Alpine Immune Sciences based?
Alpine Immune Sciences's address is: 188 East Blaine Street, Seattle, WA, United States, 98102
What is Alpine Immune Sciences's ISIN number?
Alpine Immune Sciences's international securities identification number is: US02083G1004
What is Alpine Immune Sciences's CUSIP number?
Alpine Immune Sciences's Committee on Uniform Securities Identification Procedures number is: 02083G100

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site